Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $0.40 by 385 percent. This is a 248.05 percent decrease over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $119.600 million which beat the analyst consensus estimate of $110.985 million by 7.76 percent. This is a 19.26 percent increase over sales of $100.283 million the same period last year.